フランス - フランス語 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

zydus france - azithromycine 250 mg sous forme de : azithromycine dihydratée - comprimé - 250 mg - pour un comprimé > azithromycine 250 mg sous forme de : azithromycine dihydratée - antibacteriens a usage systemique - classe pharmacothérapeutique : antibactériens à usage systémique - code atc : j01fa10.ce médicament est un antibiotique antibactérien de la famille des macrolides.il est indiqué dans le traitement de certaines infections bactériennes à germes sensibles.

フランス - フランス語 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sandoz - azithromycine 250 mg sous forme de : azithromycine dihydratée - comprimé - 250 mg - pour un comprimé > azithromycine 250 mg sous forme de : azithromycine dihydratée - antibacteriens a usage systemique - classe pharmacothérapeutique : antibactériens à usage systémique - code atc : j01fa10.ce médicament est un antibiotique antibactérien de la famille des macrolides.il est indiqué dans le traitement de certaines infections bactériennes à germes sensibles.

フランス - フランス語 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

krka, dd, novo mesto - azithromycine 250 mg sous forme de : azithromycine dihydratée - comprimé - 250 mg - pour un comprimé > azithromycine 250 mg sous forme de : azithromycine dihydratée - antibactériens à usage systémique - classe pharmacothérapeutique : antibactériens à usage systémique - code atc : j01fa10 (j : anti-infectieux).ce médicament est un antibiotique antibactérien de la famille des macrolides.il est indiqué dans le traitement de certaines infections bactériennes à germes sensibles.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see dosage and administration (2)] - acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae , moraxella catarrhalis, or streptococcus

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

cardinal health - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see dosage and administration (2)] [see use in specific populations (8.4) and clinical studies (14.2)] azithromycin should not be used in patients with pneumonia

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

central texas community health centers - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see dosage and administration (2)] - acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae , moraxella catarrhalis, or streptococcus

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin tablets, are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see dosage and administration (2)] .   - acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae , moraxella catarrhalis , or streptococcus pneumoniae . - acute bacterial sinusitis due to haemophilus influenzae , moraxella catarrhalis  or streptococcus pneumoniae . - community-acquired pneumonia due to chlamydophila pneumoniae , haemophilus influenzae , mycoplasma pneumoniae , or streptococcus pneumoniae in patients appropriate for oral therapy. - pharyngitis/tonsillitis caused by streptococcus pyogenes  as an alternative to first-line therapy in individuals who cannot use first-line therapy. - uncomplicated skin and skin structure infectio

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

unit dose services - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin tablets, are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see dosage and administration (2)] .   - acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae , moraxella catarrhalis , or streptococcus pneumoniae . - acute bacterial sinusitis due to haemophilus influenzae , moraxella catarrhalis  or streptococcus pneumoniae . - community-acquired pneumonia due to chlamydophila pneumoniae , haemophilus influenzae , mycoplasma pneumoniae , or streptococcus pneumoniae in patients appropriate for oral therapy. - pharyngitis/tonsillitis caused by streptococcus pyogenes  as an alternative to first-line therapy in individuals who cannot use first-line therapy. - uncomplicated skin and skin structure infectio

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

direct rx - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin tablets are macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see dosage and administration (2)] 1.1 adult patients acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae, moraxella catarrhalis, or streptococcus pneumoniae. acute bacterial sinusitis due to haemophilus influenzae, moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae, mycoplasma pneumoniae, or streptococcus pneumoniae in patients appropriate for oral therapy. pharyngitis/tonsillitis caused by streptococcus pyogenes as an alternative to first-line therapy in individu

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

avpak - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg